University of California San Francisco
San Francisco, California, United States
Purpose
to test the hypothesis that addition of blockade of type I interferon (IFN) activity to anti-retroviral therapy (ART) will facilitate immune-mediated clearance of human immunodeficiency virus (HIV), allowing for elite control off of ART
Division
Global Health
Date
December 2014
Region Served
GLOBAL
Committed amount
$239,906
Grant topic
HIV
Duration (months)
47
Grantee location
San Francisco, California, United States
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.